HU175266B - Sposob poluchenija materialy dezacetil 890 a1 i dezacetil 890 a3 - Google Patents

Sposob poluchenija materialy dezacetil 890 a1 i dezacetil 890 a3

Info

Publication number
HU175266B
HU175266B HUME002031A HU175266B HU 175266 B HU175266 B HU 175266B HU ME002031 A HUME002031 A HU ME002031A HU 175266 B HU175266 B HU 175266B
Authority
HU
Hungary
Prior art keywords
dezacetyl
producing
producing dezacetyl
Prior art date
Application number
Other languages
English (en)
Hungarian (hu)
Inventor
Jean S Kahan
Frederick M Kahan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HU175266B publication Critical patent/HU175266B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUME002031 1975-11-24 1976-11-18 Sposob poluchenija materialy dezacetil 890 a1 i dezacetil 890 a3 HU175266B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63456075A 1975-11-24 1975-11-24

Publications (1)

Publication Number Publication Date
HU175266B true HU175266B (hu) 1980-06-28

Family

ID=24544292

Family Applications (1)

Application Number Title Priority Date Filing Date
HUME002031 HU175266B (hu) 1975-11-24 1976-11-18 Sposob poluchenija materialy dezacetil 890 a1 i dezacetil 890 a3

Country Status (16)

Country Link
JP (1) JPS5265295A (enrdf_load_stackoverflow)
AR (1) AR224224A1 (enrdf_load_stackoverflow)
AU (1) AU510252B2 (enrdf_load_stackoverflow)
BE (1) BE848349A (enrdf_load_stackoverflow)
CH (1) CH625803A5 (enrdf_load_stackoverflow)
DE (1) DE2652678A1 (enrdf_load_stackoverflow)
DK (1) DK497476A (enrdf_load_stackoverflow)
ES (1) ES453508A1 (enrdf_load_stackoverflow)
FR (1) FR2351979A1 (enrdf_load_stackoverflow)
GB (1) GB1561108A (enrdf_load_stackoverflow)
GR (1) GR61407B (enrdf_load_stackoverflow)
HU (1) HU175266B (enrdf_load_stackoverflow)
NL (1) NL7612932A (enrdf_load_stackoverflow)
PT (1) PT65845B (enrdf_load_stackoverflow)
SE (1) SE7612295L (enrdf_load_stackoverflow)
ZA (1) ZA766986B (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7800979L (sv) * 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
SE7800978L (sv) * 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
US4162193A (en) * 1977-08-19 1979-07-24 Merck & Co., Inc. Enzymatic cleavage of N-acyl-thienamycins
NZ190994A (en) 1978-07-24 1981-10-19 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates
EP0024447B1 (en) * 1979-08-28 1983-07-20 Merck & Co. Inc. Process for purifying thienamycin
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen
US10695322B2 (en) 2016-01-29 2020-06-30 The Johns Hopkins University Inhibitors of bacterial growth

Also Published As

Publication number Publication date
BE848349A (fr) 1977-05-16
PT65845B (en) 1978-10-10
GR61407B (en) 1978-11-11
CH625803A5 (en) 1981-10-15
FR2351979A1 (fr) 1977-12-16
ZA766986B (en) 1978-06-28
FR2351979B1 (enrdf_load_stackoverflow) 1982-08-13
NL7612932A (nl) 1977-05-26
DK497476A (da) 1977-05-25
AU1964576A (en) 1978-05-25
PT65845A (en) 1976-12-01
SE7612295L (sv) 1977-05-25
GB1561108A (en) 1980-02-13
ES453508A1 (es) 1978-03-01
AU510252B2 (en) 1980-06-19
JPS5265295A (en) 1977-05-30
AR224224A1 (es) 1981-11-13
DE2652678A1 (de) 1977-06-02

Similar Documents

Publication Publication Date Title
HU175045B (hu) Sposob i apparat dlja poluchenija kultury kletok
HU178128B (en) Process for producing corticosteroides
HU174850B (hu) Sposob poluchenija slozhnykh 17-al'fa-efirov 21-galogeno-pregnanov
PH11580A (en) Process for producing n-acyl-l-methionine
GB1550230A (en) Phenylindolines and process for their production
JPS51122187A (en) Cyclopenteneedicyclopentadiene copolymers and process for producing same
HU172483B (hu) Sposob poluchenija benzimidazol-karbamatov
JPS5243896A (en) Impacttresistant resin and process for producing same
HU179275B (en) Process for producing 11-deoxy-16-aryloxy-omega-tetra prrostaglandines
HU174191B (hu) Sposob poluchenija soedinenijj acilamino-oksadiazola i -tiadiazola
HU171083B (hu) Sposob poluchenija l-3-skobka-3-zapjataja vverkh-zapjataja vniz-4-zapjataja vverkh-digidroksi-fenil-skobka zakryta-2-metil-alanin-peptidov
JPS524536A (en) 22hydroxybenzantron and process for producing substituted derivatives thereof
IL49568A0 (en) Anthraquinone-bis-amidines and process for preparing them
HU172441B (hu) Sposob poluchenija omega-skobka-arilsul'fonamido-skobka
JPS5283350A (en) Substituted 11alkenyllchclohexanol and chclohexene and process for manufacture thereof
YU40656B (en) Process for producing ethylchlorothioformate
HU175266B (hu) Sposob poluchenija materialy dezacetil 890 a1 i dezacetil 890 a3
HU173926B (hu) Sposob poluchenija 3-fenoksi-benzaldehidov
YU262176A (en) Process for obtaining aroyl-phenylindene and aroyl-phenylnaphthaline
JPS526793A (en) Modified rubberrlike terpolymers and process for producing same
HU172481B (hu) Sposob poluchenija 2-alkil-indanov
CY956A (en) Fluoro-prostaglandins and process for their preparation
GR60443B (en) D-homosteroids and process for their preparation
IL49716A0 (en) New thienyl-prostaglandins and process for their manufacture
HU172998B (hu) Sposob poluchenija 2-gidroksimetil-3-gidroksi-6-skobka-1-zapjataja vverkh-gidroksi-2-zapjataja vverkh-terc butil-amino-etil-skobka zakryta piridin-digidrokhlorida